Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
beta-1,3-N-acetylgalactosaminyltransferase 2

Summary
Gene Symbol
  • B3GALNT2
Aliases
  • MGC39558
Organism
Homo sapiens (human)
NCBI Gene
148789
GGDB ID
HGNC
28596
mRNA
map
  • 1q42.3
Protein
OMIM
KEGG Gene ID
hsa:148789
PubChem
148789
Alliance of Genome Resources
Annotation
Keyword
  • Alternative splicing
  • Congenital muscular dystrophy
  • Disease variant
  • Dystroglycanopathy
  • Endoplasmic reticulum
  • Glycoprotein
  • Glycosyltransferase
  • Golgi apparatus
  • Lissencephaly
  • Reference proteome
  • Signal-anchor
  • Transmembrane helix
Proteins
Displaying 1 entry
UniProt Protein Name
Q8NCR0
  • Beta-1,3-N-acetylgalactosaminyltransferase II
Annotation information from UniProt.
Gene Ontology (GO)
Gene Ontology information from NCBI Gene and UniProt.
OrthoDB (Group)
Group level
Eukaryota
Group Name
Galactosyltransferase
Functional Category
  • K: Transcription
  • M: Cell wall/membrane/envelope biogenesis
  • T: Signal transduction mechanisms
Displaying all 2 entries
Gene Ontology
hexosyltransferase activity
transferase activity
Displaying 1 entry
InterPro
Glycosyl transferase, family 31
GlycoGene Database (GGDB)
GGDB ID
gg103
Gene Symbol
  • B3GALNT2
Reactions
Displaying all 3 entries
Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
UDP-GalNAc
G97041TX
MU
G82715NG
MU
UDP-GalNAc
G00033MO
Ser/Thr
G01707KB
Ser/Thr
UDP-GalNAc
G49108TO
R
G36387CV
R
Displaying entries 1 - 5 of 8 in total
Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
UDP-GalNAc
G00033MO
(core2)-pNP
G01707KB
(core2)-pNP
UDP-GalNAc
G97041TX
MU
G82715NG
MU
UDP-GalNAc
G00033MO
Ser/Thr
G01707KB
Ser/Thr
UDP-GalNAc
G00035MO
(core3)-pNP
G18975PJ
(core3)-pNP
UDP-GalNAc
G42666HT
Bz
G37177QE
Bz
Displaying entries 1 - 5 of 19 in total
Donor Acceptor Reducing terminal(Acceptor) Reference
UDP-GalNAc
G84224TW
Cer
UDP-GalNAc
G84088FO
pNP
UDP-GalNAc
G49108TO
[alpha]-Bz
UDP-GalNAc
G71142DF
[beta]-pNP
UDP-GalNAc
G96881BQ
[alpha]-pNP
Orthologous Gene
Displaying all 2 entries
Species Protein mRNA
Rattus norvegicus XP_225436 XM_225436
Mus musculus NP_848755 NM_178640
KEGG BRITE Database
Orthology
K09654
Name
beta-1,3-N-acetylgalactosaminyltransferase 2 [EC:2.4.1.313]
References
Reactions
Displaying 1 entry
KEGG Reaction Enzyme Acceptor Product
R07614
Rhea

RHEA:37667

UDP-N-acetyl-α-D-galactosamine
H+ + UDP
Enzyme
PMID
Disease
Disease Ontology
Displaying 1 entry
DO ID Disease Name Source
DOID:0111230 congenital muscular dystrophy-dystroglycanopathy type A11
The Human Phenotype Ontology
Displaying entries 1 - 10 of 78 in total
HPO ID HPO Term
HP:0000007 Autosomal recessive inheritance
HP:0000028 Cryptorchidism
HP:0000175 Cleft palate
HP:0000176 Submucous cleft hard palate
HP:0000193 Bifid uvula
HP:0000238 Hydrocephalus
HP:0000252 Microcephaly
HP:0000256 Macrocephaly
HP:0000358 Posteriorly rotated ears
HP:0000369 Low-set ears
Displaying all 3 entries
Disease ID Disease Name
ORPHA:588
  • muscle-eye-brain disease
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1
ORPHA:899
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8
  • muscular dystrophy-dystroglycanopathy, type A
OMIM:615181
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11
PubChem Disease
MedGen Diseases
OMIM Phenotypes
KEGG Diseases
Gene-Disease-Co-Occurrences-in-Literature (PubChem)
Ortholog
Displaying entries 41 - 50 of 74 in total
Species Gene ID OrthoDB Alliance of Genome Resources Orthologous MAtrix
103178875 CALMI16489
103230797 CHLSB12320
103254834 CARSF26105
103661896 URSMA12551
103745134 NANGA20476
103818567 SERCA14084
104679172 RHIRO00922
105474603 MACNE22900
105546243 MANLE25520
105574887 CERAT14202
About Release Notes Help Feedback
International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.1.0

Last updated: December 9, 2024